This inventor holds 3 USPTO granted patents. Top assignees: The Broad Institute, Inc., The General Hospital Corporation, The Board Institute, Inc.. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 488 
2 out of 3,076 
1 out of 7 Years Active: 2016-2020
Title: Noriakie Iwase: Innovator in Mycobacterial Infection Treatment
Introduction
Noriakie Iwase is a notable inventor based in Yamaguchi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mycobacterial infections. With a total of 3 patents to his name, Iwase's work is recognized for its potential impact on healthcare.
Latest Patents
Iwase's latest patents focus on innovative compounds for the treatment of mycobacterial infections. These inventions relate to compounds of Formula I or a pharmaceutically acceptable salt, ester, or prodrug thereof. His research aims to provide effective solutions for combating these challenging infections.
Career Highlights
Throughout his career, Noriakie Iwase has worked with prestigious organizations, including the Broad Institute, Inc. and Massachusetts General Hospital Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Iwase has had the opportunity to work alongside esteemed colleagues such as Deborah Hung and Sarah Stanley. These collaborations have further enriched his research and innovation efforts.
Conclusion
Noriakie Iwase stands out as a dedicated inventor whose work in developing treatments for mycobacterial infections holds promise for the future of medicine. His contributions continue to inspire advancements in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile